Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TENOFOVIR DISOPROXIL FUMARATE

TENOFOVIR DISOPROXIL FUMARATE

Standard Dose
150MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TENOFOVIR DISOPROXIL FUMARATE is listed in Drugs@FDA under application 206569 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient TENOFOVIR DISOPROXIL FUMARATE Form and strength TABLET;ORAL - 150MG Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2025-01-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview TENOFOVIR DISOPROXIL FUMARATE is listed in Drugs@FDA under application 206569 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TENOFOVIR DISOPROXIL FUMARATE Form and strength TABLET;ORAL - 150MG Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2025-01-28 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
TENOFOVIR DISOPROXIL FUMARATE (TENOFOVIR DISOPROXIL FUMARATE) | Drug Monograph | MedicHelpline